Shared fatigue biology across five illnesses
Analysis based on 6 articles · First reported Sep 02, 2026 · Last updated Sep 05, 2026
The study could boost Oxford BioDynamics' diagnostic platform credibility and open new markets for blood-based tests, potentially increasing its valuation. For the University of East Anglia and academic partners, the impact is reputational and may attract research funding, with limited direct market effect.
Researchers at the University of East Anglia and Oxford BioDynamics, with collaborators from the London School of Hygiene and Tropical Medicine and United Kingdom — Cornwall Partnership NHS Foundation Trust, published a study in the Journal of Translational Medicine revealing shared biological mechanisms underlying chronic fatigue in five conditions: ME/CFS, long Covid, PTSD, rheumatoid arthritis, and multiple sclerosis. Using Oxford BioDynamics' EpiSwitch Orion platform, they analyzed 3D genomic architecture and found that despite little direct genetic overlap, the conditions converge on common regulatory networks involving immune and inflammatory signaling, mitochondrial energy production, metabolic regulation, stress-response, and neuroendocrine signaling. The findings suggest a 'biological unifying theory of fatigue' and may lead to objective blood tests and cross-condition treatments. Lead researcher Dmitry Pshezhetskiy and Oxford BioDynamics' Ewan Hunter were key contributors.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard